Telix Pharmaceuticals
About:
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Website: http://www.telixpharma.com
Twitter/X: TelixPharma
Top Investors: Australian Government
Description:
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.
Total Funding Amount:
$495M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Melbourne, Victoria, Australia
Founded Date:
2015-11-01
Contact Email:
info(AT)telixpharma.com
Founders:
Christian Behrenbruch
Number of Employees:
101-250
Last Funding Date:
2024-07-23
IPO Status:
Public
Industries:
© 2025 bioDAO.ai